Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort study

Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort study

Abstract Introduction Individual variability of rivaroxaban was observed in clinical application. This study aimed to identify genetic variants associated with the variability of pharmacodynamics and bleeding risk of rivaroxbaban in patients with nonvalvular atrial fibrillation (NVAF). Materials and...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Qian Xiang, Zhe Wang, Guangyan Mu, Qiufen Xie, Zhiyan Liu, Shuang Zhou, Hanxu Zhang, Zining Wang, Jie Jiang, Kun Hu, Yatong Zhang, Zinan Zhao, Dongdong Yuan, Liping Guo, Tingting Wu, Jinhua Zhang, Na Wang, Jing Xiang, Zhichun Gu, Jianjun Sun, Yimin Cui
Μορφή: Άρθρο
Γλώσσα:English
Έκδοση: Wiley 2023-05-01
Σειρά:Clinical and Translational Medicine
Θέματα:
atrial fibrillation
bleeding
genetic polymorphism
pharmacodynamics
rivaroxaban
Διαθέσιμο Online:https://doi.org/10.1002/ctm2.1263

Διαδίκτυο

https://doi.org/10.1002/ctm2.1263

Παρόμοια τεκμήρια